Identification and Validation of a m6A ‐Related Long Noncoding RNA Prognostic Model in Colorectal Cancer
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Peng Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Colorectal Neoplasms, Adenosine, Biomarkers, Tumor. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Liaoning Province, National Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Accumulating research indicates that N6‐methyladenosine (m6A) modification plays a pivotal role in colorectal cancer (CRC). Hence, investigating the m6A‐related long noncoding RNAs (lncRNAs) significantly improves therapeutic strategies and prognostic assessments. This study aimed to develop and validate a prognostic model based on m6A‐related lncRNAs to improve the prediction of clinical outcomes and identify potential immunological mechanisms in CRC. We obtained high‐throughput CRC data from The Cancer Genome Atlas to identify a prognostic model based on m6A‐related lncRNAs. Then, the model was constructed and validated through LASSO analysis and Cox regression using R software. The clinical applicability was enhanced by developing a nomogram. We further conducted experiments to reveal the biological function of LINC00543. The prognostic model based on eight m6A‐related lncRNAs exhibited impressive accuracy, achieving an area under the receiver‐operating curve value of 0.753, 0.682 and 0.706 for predictions after 1, 3 and 5 years, respectively. The Kaplan–Meier analysis confirmed the consistency of the model across different pathological characteristics, with a high‐risk group showing a poorer prognosis. Furthermore, the model was linked to immune function, particularly the type I interferon response, through gene set enrichment analysis and experimental validation. Our study presented a m6A‐related lncRNA prognostic model for CRC with potential clinical utility. The model not only provided improved accuracy over traditional staging but also offered insights into the immunological mechanisms of CRC, facilitating personalised medicine approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.
- Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, Shenyang, China.
ORCID-Profile: Mingfei Chu
Förderung
- Natural Science Foundation of Liaoning Province
- National Science Fund for Distinguished Young Scholars
Zitieren
APA
Jiang, P., Chu, M., & Liang, Y. (2025). Identification and Validation of a m6A ‐Related Long Noncoding RNA Prognostic Model in Colorectal Cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70376
Vancouver
Jiang P, Chu M, Liang Y. Identification and Validation of a m6A ‐Related Long Noncoding RNA Prognostic Model in Colorectal Cancer. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70376
BibTeX
@article{Jiang2025,
author = {Jiang, Peng and Chu, Mingfei and Liang, Yu},
title = {Identification and Validation of a m6A ‐Related Long Noncoding RNA Prognostic Model in Colorectal Cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70376}
}
EUVIMED